Skip to content
cell-gene-therapy-research-area-banner-v5

IN VITRO
CELL & GENE THERAPY
ASSAY SERVICES

Gain insights into your cell and gene therapies with our in vitro Ready-2-Go assay services, or collaborate with our team to build your customized assay.

THE TRANSFORMATIVE POTENTIAL
OF CELL & GENE THERAPIES

As our understanding of various disease pathologies continues to grow, so too do the strategies for developing effective and safe treatments. Cell and gene therapies have emerged as promising approaches to treating myriad areas, from cancer to neurodegeneration. Cell therapies transfer live cells into a patient to treat a disease, and these cells can be autologous (from the patient) or allogeneic (from a donor). Gene therapies deliver genetic material (DNA or RNA) to treat or prevent diseases at their source, typically aiming to either restore proper protein function or reduce levels of a problematic protein. Whether you are working on cell or gene therapies, or both, we offer a range of in vitro assay services for you to choose from.

READY-2-GO ASSAY SERVICES

Choose from a list of predefined, in vitro assay offerings designed to deliver high-quality data, fast.

aav-gene-delivery-icon

R2G AAV GENE DELIVERY

Assess AAV transduction in various cell types.
Learn more

neurotoxicity-icon

R2G NEUROTOXICITY

Multiplexed readouts of viability and apoptosis.
Learn more

cell-health-icon

R2G CELL HEALTH

Multiplexed readouts of proliferation, viability, and apoptosis.
Learn more

APPLICABLE DISEASES

Preclinical Toxicity Oncology Pulmonary Fibrosis NASH/Liver Cirrhosis Neurodegen.
(AD, PD, MS)
Psychiatric Disorders Neuro-development
R2G AAV Gene Delivery
R2G Neurotoxicity
R2G Cell Health
cp-lines-section-break

BUILD YOUR OWN CUSTOM ASSAY

Can't find what you need? Collaborate with our team to design a custom assay suited to your research needs.

  • In vitro models
  • Assay Types
  • Therapeutic Modalities

Examples of in vitro models we use in mono- or multi-cultures:

  • Cell lines
  • Primary cells/material
  • iPSC-derived cells, including CNS-related cell types 
  • Patient-derived xenografts 
  • 2D or 3D formats

map2aav

 

Examples of assays we deliver:

  • Viral-vector uptake/transduction 
  • T-cell invasion/killing 
  • Cellular or subcellular localization 
  • Time-lapsed (live or fixed) measurements 

CardioAAV_Composite5

 

Examples of therapeutic modalities we test:

  • Viral vectors (e.g., AAV, lentivirus)
  • Nanoparticles 
  • Lipids
  • Peptides
  • CAR-T cells

HepatoAAV_Composite2

 

RESOURCES

CardioAAV_Composite3

CONTACT US

Let's discuss how we can help with your research.

car-t-blog-page-1200x627

BLOG POST | 6 MIN READ

Advancements in CAR-T Therapy & Research

Learn about the progress and challenges in developing Chimeric Antigen Receptor T-cell (CAR-T) therapies and its potential applications in oncology research.

Human, iPSC-derived cardiomyocytes transduced with AAV carrying a GFP gene.

BLOG POST | 6 MIN READ

AAVs in Gene Therapy

Learn more about the significance of AAVs as gene-therapy vectors and practical considerations for their use.

cardio-aav-1200x627

BLOG POST | 4 MIN READ

Advancing Gene Delivery with Dual-AAV Therapy

Discover how dual-AAV therapy is revolutionizing gene delivery and its promising potential in research and treatment.